Table 2.
Therapeutic molecule class |
Example molecules | Polymer delivery system | Solvent | Electrospinning setup |
Fiber diameter^ |
In vitro drug release |
Refs |
---|---|---|---|---|---|---|---|
Antimicrobial | Fusidic acid | Poly(lactide-co-glycolide) | Dichloromethane | Standard | 200 nm–2 µm | 9–15 days | [151,152] |
Linezolid | Poly(ε-caprolactone) | Acetone | Standard | 450–800 nm | 1–14 days | [153] | |
Poly(L-lactic acid) | Hexafluoroisopropanol | Standard, co-axial | 260 nm–2 µm | 1 — at least 5 days | [178] | ||
Tetracycline hydrochloride | Poly(ethylene-co-vinyl acetate), poly(lactic acid), and their blends |
Chloroform/methanol | Standard | 1–6 µm | Hours to at least 5 days | [255] | |
Iodine | Poly(vinyl pyrrolidone) (PVP) and poly(ethylene oxide)/PVP |
Water | Standard* | 230–730 nm | Data not available | [155] | |
Cefazolin | Poly(lactide-co-glycolide) | Tetrahydrofuran/dimethylformamide | Standard | 450–500 nm | Data not available | [147] | |
Mupirocin | Poly(L-lactic acid) | Hexafluoroisopropanol | Standard, dual | Data not available | At least 3 days | [140] | |
Silver nanoparticles | Poly(ε-caprolactone) | Acetone | Standard | 2–4.3 µm | Data not available | [156] | |
Zein | Citric acid in ethanol | Standard | 350–500 nm | Data not available | [157] | ||
Poly(dopamine methacrylamide-co-methyl methacrylate) |
Dimethylformamide | Standard | 800 nm | At least 7 days | [158] | ||
Gentamycin sulfate | Polycaprolactone | Chloroform (shell)/distilled water (core) |
Coaxial | 153 nm–1.7 µm | 7 days | [149] | |
Cefoxitin sodium | Poly(lactic-co-glycolic acid) (PLGA) | Dimethylformamide/water | Standard | 260 nm | 7 days | [148] | |
Antifungal | Itraconazole | Polyurethane | Dimethylformamide | Standard | 300 nm–2 µm | 24 h | [141] |
Antioxidant | Vitamin E | Silk fibroin | Water | Standard | 380–723 nm | 3 days | [172] |
Green tea polyphenols | Poly(lactide-co-glycolide) | Acetone/dimethylformamide | Standard | 780 nm | 10–14 days | [177] | |
Vitamin A | Cellulose acetate | Acetone/dimethylacetamide | Standard | 250 nm | 6 days | [173] | |
Resveratrol | Polycaprolactone | Chloroform (shell)/ethanol(core) | Coaxial | 147 nm–1.6 µm | 7 days | [149] | |
Anti-proliferative | Dexamethasone | Poly(lactide-co-glycolide) | Acetone/dimethylformamide | Standard | 780 nm | At least 25 days | [177] |
Local anesthetic | Bupivacaine | Poly(lactide-co-glycolide) | Hexafluoroisopropanol | Standard | 800 nm–1 µm | 12 days | [174] |
Vancomycin Gentamicin |
Poly(lactide-co-glycolide)/collagen | Hexafluoroisopropanol | Standard, multiple |
55–314 nm | At least 21 days | [175] | |
Lidocaine | Poly(L-lactic acid) | Hexafluoroisopropanol | Standard, dual | Data not available | 15 days 1 h–3 days |
[140] | |
Wound healing | Epidermal growth factor | Poly(ε-caprolactone)/hyaluronic acid | Chloroform/formic acid/water | Standard | 150 nm | At least 30 days | [161] |
Basic fibroblast growth factor | Poly(ethylene glycol)-Poly(DL-lactide) | Chloroform/PBS | Standard | 780 nm | 25 days | [165] | |
Hyaluronic acid | Sodium hydroxide/dimethylformamide | Dual | 486 nm | 5 days | [167] | ||
Ketanserin | Polyurethane | Dimethylacetamide | Standard | 500 nm–2 µm | 24 h | [141] | |
Vascular endothelial growth factor |
Gelatin nanoparticles in hyaluronic acid | Sodium hydroxide/dimethylformamide | Dual | 486–534 nm | 28 days | [167] | |
Platelet-derived growth factor | Gelatin nanoparticles in collagen | Acetic acid | 28 days | ||||
Endothelial growth factor | Collagen | Acetic acid | 21 days |
Polymer was electrospun using a standard electrospinning setup, however, therapeutic molecule was loaded after.
Fiber diameter is reported as a range if the authors investigated the effects of electrospinning parameters on fiber morphology.